This discrepancy between the uptake in tumor and GRPR-expressing organs was previously reported for the same conjugates labeled with 111In16 and for other radiolabeled bombesin analogues23–25 and is most likely due to differences in affinity towards human and murine GRPR. This evidence concerns the gene GRP and neoplasm.